Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comorbidities significantly impact patients’ preferences for psoriasis treatments
Astrid Schmieder, Marthe‐Lisa Schaarschmidt, Nasir Umar, et al.
Journal of the American Academy of Dermatology (2011) Vol. 67, Iss. 3, pp. 363-372
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
Josef S Smolen, J. Braun, Maxime Dougados, et al.
Annals of the Rheumatic Diseases (2013) Vol. 73, Iss. 1, pp. 6-16
Open Access | Times Cited: 431
Macrophage activation in human diseases
Joachim L. Schultze, Astrid Schmieder, Sergij Goerdt
Seminars in Immunology (2015) Vol. 27, Iss. 4, pp. 249-256
Closed Access | Times Cited: 119
Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review
Aleksandra G. Florek, Catherine J. Wang, April W. Armstrong
Archives of Dermatological Research (2018) Vol. 310, Iss. 4, pp. 271-319
Closed Access | Times Cited: 118
Epidemiology of mental health comorbidity in patients with psoriasis: An analysis of trends from 1986 to 2019
Liu Liu, Naixuan Lin, Yuanting Yu, et al.
Psychiatry Research (2023) Vol. 321, pp. 115078-115078
Closed Access | Times Cited: 26
Risk as an Attribute in Discrete Choice Experiments: A Systematic Review of the Literature
Mark Harrison, Dan Rigby, Caroline Vass, et al.
Patient (2014) Vol. 7, Iss. 2, pp. 151-170
Closed Access | Times Cited: 95
Incremental Effects of Comorbidity on Quality of Life in Patients with Psoriatic Arthritis
Janice Husted, Arane Thavaneswaran, Vinod Chandran, et al.
The Journal of Rheumatology (2013) Vol. 40, Iss. 8, pp. 1349-1356
Open Access | Times Cited: 93
Preference for pharmaceutical formulation and treatment process attributes
Katie D. Stewart, Joseph A. Johnston, Louis S. Matza, et al.
Patient Preference and Adherence (2016) Vol. Volume 10, pp. 1385-1399
Open Access | Times Cited: 82
Suicide risk and psychiatric comorbidity in patients with psoriasis
Maurizio Pompili, Marco Innamorati, Sara Trovarelli, et al.
Journal of International Medical Research (2016) Vol. 44, Iss. 1_suppl, pp. 61-66
Open Access | Times Cited: 65
Patient preferences for psoriasis treatments: impact of treatment experience
Marthe‐Lisa Schaarschmidt, Nasir Umar, Astrid Schmieder, et al.
Journal of the European Academy of Dermatology and Venereology (2012) Vol. 27, Iss. 2, pp. 187-198
Closed Access | Times Cited: 63
Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment
Christian Kromer, Marthe‐Lisa Schaarschmidt, Astrid Schmieder, et al.
PLoS ONE (2015) Vol. 10, Iss. 6, pp. e0129120-e0129120
Open Access | Times Cited: 57
Matching physicians’ treatment recommendations to patients’ treatment preferences is associated with improvement in treatment satisfaction
Nasir Umar, Marthe‐Lisa Schaarschmidt, Astrid Schmieder, et al.
Journal of the European Academy of Dermatology and Venereology (2012) Vol. 27, Iss. 6, pp. 763-770
Closed Access | Times Cited: 53
Barriers to guideline‐compliant psoriasis care: analyses and concepts
L. Eissing, Marc Alexander Radtke, N. Zander, et al.
Journal of the European Academy of Dermatology and Venereology (2015) Vol. 30, Iss. 4, pp. 569-575
Closed Access | Times Cited: 42
Recommendations for Initiating Systemic Therapy in Patients with Psoriasis.
George M. Martin, Melodie Young, Lakshi Aldredge
PubMed (2019) Vol. 12, Iss. 4, pp. 13-26
Closed Access | Times Cited: 36
A systematic review on methods used to evaluate patient preferences in psoriasis treatments
M. Gutknecht, Marthe‐Lisa Schaarschmidt, O. Herrlein, et al.
Journal of the European Academy of Dermatology and Venereology (2016) Vol. 30, Iss. 9, pp. 1454-1464
Closed Access | Times Cited: 32
Eliciting Preferences to Inform Patient-Centred Policies: the Case of Psoriasis
Aleksandra Torbica, Giovanni Fattore, Fabio Ayala
PharmacoEconomics (2014) Vol. 32, Iss. 2, pp. 209-223
Closed Access | Times Cited: 34
Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders
Maurizio Pompili, Marco Innamorati, Alberto Forte, et al.
International Journal of Psychiatry in Clinical Practice (2017) Vol. 21, Iss. 3, pp. 209-214
Closed Access | Times Cited: 33
Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment
Juan Marcos González, F. Reed Johnson, Helen McAteer, et al.
British Journal of Dermatology (2016) Vol. 176, Iss. 3, pp. 777-785
Closed Access | Times Cited: 29
The importance of understanding patient and physician preferences for psoriasis treatment characteristics: a systematic review of discrete-choice experiments
Noem Sain, D. Willems, M. Charokopou, et al.
Current Medical Research and Opinion (2020) Vol. 36, Iss. 8, pp. 1257-1275
Open Access | Times Cited: 24
Risk of Depression in Patients With Psoriatic Disease: A Systematic Review and Meta-Analysis
Aysha Lukmanji, Robert B. Basmadjian, Isabelle A. Vallerand, et al.
Journal of Cutaneous Medicine and Surgery (2020) Vol. 25, Iss. 3, pp. 257-270
Closed Access | Times Cited: 24
Patients’ and Physicians’ Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare)
Marthe‐Lisa Schaarschmidt, Raphael M. Herr, M. Gutknecht, et al.
Acta Dermato Venereologica (2017) Vol. 98, Iss. 2, pp. 200-205
Open Access | Times Cited: 28
Modeling Heterogeneity in Patients’ Preferences for Psoriasis Treatments in a Multicountry Study: A Comparison Between Random-Parameters Logit and Latent Class Approaches
Marco Boeri, Daniel Saure, Alexander Schacht, et al.
PharmacoEconomics (2020) Vol. 38, Iss. 6, pp. 593-606
Closed Access | Times Cited: 23
Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients
Marthe‐Lisa Schaarschmidt, Christian Kromer, Raphael M. Herr, et al.
PLoS ONE (2015) Vol. 10, Iss. 12, pp. e0144335-e0144335
Open Access | Times Cited: 22
Understanding Patient Preferences in Medication Nonadherence: A Review of Stated Preference Data
Tracey‐Lea Laba, Beverley M. Essue, Merel Kimman, et al.
Patient (2014) Vol. 8, Iss. 5, pp. 385-395
Closed Access | Times Cited: 20
Evaluating Risk Tolerance from a Systematic Review of Preferences: The Case of Patients with Psoriasis
Juan Marcos González
Patient (2018) Vol. 11, Iss. 3, pp. 285-300
Closed Access | Times Cited: 19
Patient Preferences Associated with Therapies for Psoriatic Arthritis: A Conjoint Analysis.
Yihua Xu, Lavanya Sudharshan, Ming‐Ann Hsu, et al.
PubMed (2018) Vol. 11, Iss. 8, pp. 408-417
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top